210 related articles for article (PubMed ID: 17481662)
1. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
Ranoux D; Attal N; Morain F; Bouhassira D
Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.
Krämer HH; Angerer C; Erbguth F; Schmelz M; Birklein F
J Neurol; 2003 Feb; 250(2):188-93. PubMed ID: 12574949
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.
Tugnoli V; Capone JG; Eleopra R; Quatrale R; Sensi M; Gastaldo E; Tola MR; Geppetti P
Pain; 2007 Jul; 130(1-2):76-83. PubMed ID: 17194546
[TBL] [Abstract][Full Text] [Related]
6. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Piovesan EJ; Teive HG; Kowacs PA; Della Coletta MV; Werneck LC; Silberstein SD
Neurology; 2005 Oct; 65(8):1306-8. PubMed ID: 16247065
[TBL] [Abstract][Full Text] [Related]
7. A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model.
Sycha T; Samal D; Chizh B; Lehr S; Gustorff B; Schnider P; Auff E
Anesth Analg; 2006 Feb; 102(2):509-16. PubMed ID: 16428552
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of adrenosensitivity in capsaicin induced hyperalgesia.
Schattschneider J; Zum Buttel I; Binder A; Wasner G; Hedderich J; Baron R
Eur J Pain; 2007 Oct; 11(7):756-63. PubMed ID: 17234439
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain.
Bach-Rojecky L; Lacković Z
Croat Med J; 2005 Apr; 46(2):201-8. PubMed ID: 15849840
[TBL] [Abstract][Full Text] [Related]
11. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
Yucel A; Ozyalcin S; Koknel Talu G; Kiziltan E; Yucel B; Andersen OK; Arendt-Nielsen L; Disci R
Eur J Pain; 2005 Aug; 9(4):407-16. PubMed ID: 15979021
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
[TBL] [Abstract][Full Text] [Related]
13. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
Sándor K; Helyes Z; Elekes K; Szolcsányi J
Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
[TBL] [Abstract][Full Text] [Related]
14. Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.
Kraft B; Frickey NA; Kaufmann RM; Reif M; Frey R; Gustorff B; Kress HG
Anesthesiology; 2008 Jul; 109(1):101-10. PubMed ID: 18580179
[TBL] [Abstract][Full Text] [Related]
15. Two types of C nociceptors in human skin and their behavior in areas of capsaicin-induced secondary hyperalgesia.
Serra J; Campero M; Bostock H; Ochoa J
J Neurophysiol; 2004 Jun; 91(6):2770-81. PubMed ID: 14762154
[TBL] [Abstract][Full Text] [Related]
16. The effect of intravenous ketorolac on capsaicin-induced deep tissue hyperalgesia.
Kumar K; Polston GR; Wallace MS
Anesth Analg; 2006 Sep; 103(3):696-702. PubMed ID: 16931683
[TBL] [Abstract][Full Text] [Related]
17. Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models.
Favre-Guilmard C; Auguet M; Chabrier PE
Eur J Pharmacol; 2009 Sep; 617(1-3):48-53. PubMed ID: 19576881
[TBL] [Abstract][Full Text] [Related]
18. Psychophysics, flare, and neurosecretory function in human pain models: capsaicin versus electrically evoked pain.
Geber C; Fondel R; Krämer HH; Rolke R; Treede RD; Sommer C; Birklein F
J Pain; 2007 Jun; 8(6):503-14. PubMed ID: 17434803
[TBL] [Abstract][Full Text] [Related]
19. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
[TBL] [Abstract][Full Text] [Related]
20. Analgesic effects of low-dose intravenous orphenadrine in the state of capsaicin hyperalgesia. A randomised, placebo-controlled, double-blind cross-over study using laser somatosensory evoked potentials obtained from capsaicin-irritated skin in healthy volunteers.
Schaffler K; Reitmeir P
Arzneimittelforschung; 2004; 54(10):673-9. PubMed ID: 15553107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
